Adaptive Biotechnologies (ADPT) Inventory (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Inventory data on file, last reported at $11.2 million in Q1 2026.

• Quarterly Inventory rose 29.04% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (up 29.04% YoY) and the FY2025 annual result came in at $9.8 million, up 16.35% from the prior year.
• Inventory grew to $11.2 million in Q1 2026 per ADPT's latest filing, from $9.8 million in the prior quarter.
• The five-year high for Inventory was $21.0 million in Q1 2022, with the low at $8.4 million in Q2 2025.
• Average Inventory over 5 years is $14.1 million, with a median of $13.3 million recorded in 2024.
• Year-over-year, Inventory tumbled 41.58% in 2024 and advanced 29.04% in 2026.
• Adaptive Biotechnologies' Inventory stood at $14.5 million in 2022, then fell by 0.03% to $14.4 million in 2023, then sank by 41.58% to $8.4 million in 2024, then advanced by 16.35% to $9.8 million in 2025, then grew by 14.11% to $11.2 million in 2026.
• Business Quant data shows ADPT's Inventory at $11.2 million in Q1 2026, $9.8 million in Q4 2025, and $9.9 million in Q3 2025.